Hu Hei[Author] - Search Results

Year	Number of Results
2009	1
2015	2
2016	3
2019	1
2020	1
2021	1
2022	8
2023	7
2024	1

1

Advances in post-translational modifications of proteins and cancer immunotherapy.

Li Y, Zhang R, Hei H. Li Y, et al. Among authors: hei h. Front Immunol. 2023 Aug 22;14:1229397. doi: 10.3389/fimmu.2023.1229397. eCollection 2023. Front Immunol. 2023. PMID: 37675097 Free PMC article. Review.

2

PGC-1α participates in tumor chemoresistance by regulating glucose metabolism and mitochondrial function.

Li Y, Hei H, Zhang S, Gong W, Liu Y, Qin J. Li Y, et al. Among authors: hei h. Mol Cell Biochem. 2023 Jan;478(1):47-57. doi: 10.1007/s11010-022-04477-2. Epub 2022 Jun 17. Mol Cell Biochem. 2023. PMID: 35713741 Review.

3

Design of new drugs for medullary thyroid carcinoma.

Li Y, Luo Z, Wang X, Zhang S, Hei H, Qin J. Li Y, et al. Among authors: hei h. Front Oncol. 2022 Dec 5;12:993725. doi: 10.3389/fonc.2022.993725. eCollection 2022. Front Oncol. 2022. PMID: 36544713 Free PMC article.

4

Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer.

Ding J, Li D, Liu X, Hei H, Sun B, Zhou D, Zhou K, Song Y. Ding J, et al. Among authors: hei h. Exp Hematol Oncol. 2022 Sep 22;11(1):59. doi: 10.1186/s40164-022-00311-z. Exp Hematol Oncol. 2022. PMID: 36138444 Free PMC article.

5

Male patients with papillary thyroid cancer have a higher risk of extranodal extension.

Hei H, Zhou B, Gong W, Zheng C, Qin J. Hei H, et al. Int J Clin Oncol. 2022 Apr;27(4):648-654. doi: 10.1007/s10147-021-02109-1. Epub 2022 Jan 8. Int J Clin Oncol. 2022. PMID: 35000041

6

Preoperative prediction of central neck metastasis in patients with clinical T1-2N0 papillary thyroid carcinoma.

Hei H, Zhou B, Gong W, Zheng C, Fang J, Qin J. Hei H, et al. Surg Today. 2023 Apr;53(4):507-512. doi: 10.1007/s00595-022-02595-4. Epub 2022 Oct 6. Surg Today. 2023. PMID: 36202940

7

Macroscopic extranodal extension is an independent predictor of lung metastasis in papillary thyroid cancer.

Hei H, Gong W, Zheng C, Zhou B, Qin J. Hei H, et al. Endocrine. 2022 Jun;77(1):73-79. doi: 10.1007/s12020-022-03045-4. Epub 2022 Apr 7. Endocrine. 2022. PMID: 35389141

8

Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity.

Maniakas A, Henderson YC, Hei H, Peng S, Chen Y, Jiang Y, Ji S, Cardenas M, Chiu Y, Bell D, Williams MD, Hofmann MC, Scherer SE, Wheeler DA, Busaidy NL, Dadu R, Wang JR, Cabanillas ME, Zafereo M, Johnson FM, Lai SY. Maniakas A, et al. Among authors: hei h. J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4652-e4665. doi: 10.1210/clinem/dgab453. J Clin Endocrinol Metab. 2021. PMID: 34147031 Free PMC article.

9

Extranodal extension is an independent predictor of extensive nodal metastasis in T1 papillary thyroid cancer.

Hei H, Li Y, Luo Z, Chai X, Zhang H, Zheng C, Zhou B, Gong W, Qin J. Hei H, et al. Langenbecks Arch Surg. 2022 Jun;407(4):1647-1652. doi: 10.1007/s00423-021-02425-0. Epub 2022 Feb 10. Langenbecks Arch Surg. 2022. PMID: 35146548

10

Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer.

Hei H, Luo Z, Zheng C, Gong W, Zhou B, Fang J, Qin J. Hei H, et al. Oral Oncol. 2023 Nov;146:106563. doi: 10.1016/j.oraloncology.2023.106563. Epub 2023 Sep 9. Oral Oncol. 2023. PMID: 37690364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year